GSK Can't Shake Calif. County's Avandia False Ad Claims

Law360, New York (February 26, 2014, 3:39 PM EST) -- A Pennsylvania federal judge on Tuesday denied GlaxoSmithKline PLC's bid to partially dismiss false advertising claims brought by Santa Clara County, Calif., over GSK's diabetes medication Avandia, rejecting its argument that the claims must be based on false advertising displayed within the county.

GSK had argued that a release included in a settlement between the company and the California attorney general in November 2012 that excluded claims for Santa Clara County residents limited the claims to residents exposed to false advertising within the county, but U.S....
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

IN RE: AVANDIA MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION


Case Number

2:07-md-01871

Court

Pennsylvania Eastern

Nature of Suit

P.I.: Personal Inj. Prod. Liability

Judge

CYNTHIA M. RUFE

Date Filed

October 18, 2007

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.